 ROCKVILLE, Md., July 14, 2021 PRNewswire -- RegeneRx Biopharmaceuticals, Inc. OTCQB: RGRX RegeneRx, a clinical-stage drug development company focused on tissue protection, repair and regeneration has released an update from its U.S. joint venture, ReGenTree LLC, regarding its progress and prospects of a pre-BLA Biologics License Application meeting with FDA. 